Table 3.
Amyotrophic lateral sclerosis (ALS) model | |||
---|---|---|---|
Rank | Series | r | Description |
12 | GSE18597 | 0.6 | Mutant SOD1(G93A) transgenic mice |
Ischemia | |||
Rank | Series | r | Description |
44 | GSE23163 | 0.56 | Ischemic/reperfusion injury in an in vivo mouse model |
49 | GSE23162 | 0.55 | Ischemic/reperfusion injury in an in vivo Gpx1 -/- transgenic mouse model |
92 | GSE28201 | 0.44 | Ischemic Mouse Brain Transcriptome |
93 | GSE33725 | 0.44 | Effect of erythropoietin on cerebral ischemia in rat |
Parkinson’s model | |||
Rank | Series | r | Description |
55 | GSE7707 | -0.49 | Mouse MPTP model of Parkinson’s disease |
Spinal chord injury | |||
Rank | Series | r | Description |
98 | GSE5296 | 0.42 | Spinal Cord Injury Murine Model |
Other | |||
Rank | Series | r | Description |
13 | GSE18356 | -0.61 | Rat model of neonatal HI encephalopathy +/- antioxidant |
19 | GSE24131 | 0.58 | Hypoxia effect on mouse neural stem cells |
41 | GSE14802 | 0.52 | Smith-Magenis and Potocki-Lupski syndrome mouse model |
54 | GSE30577 | -0.49 | Brain and Spinal cord following Lethal CVS-11 Infection in Mice |
87 | GSE25250 | -0.44 | Cerebellum from mice exposed to chronic low-level chlorpyrifos oxon |
88 | GSE12196 | 0.53 | Rat exposure to RDX |